Global
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 11.31 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
2 |
USD 10.76 B
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
3 |
USD 9.19 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
4 |
USD 5.48 B
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
5 |
USD 4.70 B
|
Sept. 30, 2024 | USD 52.62 | 1.24% |
|
Germany |
|
6 |
USD 4.26 B
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
7 |
USD 3.73 B
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
8 |
USD 3.58 B
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
9 |
USD 2.51 B
|
Sept. 30, 2024 | USD 104.71 | -0.74% |
|
United States |
|
10 |
USD 2.51 B
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
11 |
USD 2.11 B
|
Sept. 30, 2024 | USD 179.15 | 1.50% |
|
United States |
|
12 |
USD 1.99 B
|
Dec. 31, 2023 | USD 32.18 | 1.97% |
|
China |
|
13 |
USD 1.88 B
|
March 31, 2024 | USD 128.19 | -0.84% |
|
Japan |
|
14 |
USD 1.79 B
|
Sept. 30, 2024 | USD 70.19 | 2.45% |
|
United States |
|
15 |
USD 1.70 B
|
Sept. 30, 2024 | USD 71.04 | -0.07% |
|
United States |
|
16 |
USD 1.69 B
|
Sept. 30, 2024 | USD 228.83 | -0.62% |
|
United States |
|
17 |
USD 1.45 B
|
March 31, 2024 | USD 18.93 | -0.22% |
|
Japan |
|
18 |
USD 1.30 B
|
Sept. 28, 2024 | USD 70.20 | -0.13% |
|
United States |
|
19 |
USD 1.17 B
|
Sept. 30, 2024 | USD 1.27 K | 0.33% |
|
United States |
|
20 |
USD 1.11 B
|
June 30, 2024 | USD 17.28 | 1.26% |
|
Australia |
|
21 |
USD 1.02 B
|
March 31, 2024 | USD 329.06 | 0.76% |
|
Switzerland |
|
22 |
USD 975.30 M
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
23 |
USD 956.00 M
|
Dec. 31, 2023 | USD 11.94 | -0.50% |
|
United Kingdom |
|
24 |
USD 811.39 M
|
Sept. 30, 2024 | USD 210.46 | -1.51% |
|
United States |
|
25 |
USD 764.24 M
|
March 31, 2024 | USD 18.62 | 0.90% |
|
Japan |
|
26 |
USD 713.36 M
|
March 31, 2024 | USD 14.83 | 0.94% |
|
Japan |
|
27 |
USD 652.18 M
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
28 |
USD 636.70 M
|
March 31, 2024 | USD 27.11 | -0.51% |
|
Japan |
|
29 |
USD 636.02 M
|
Sept. 29, 2024 | USD 179.17 | 0.35% |
|
United States |
|
30 |
USD 610.70 M
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
31 |
USD 585.19 M
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
32 |
USD 576.16 M
|
Dec. 31, 2023 | USD 26.82 | 1.34% |
|
Italy |
|
33 |
USD 569.32 M
|
March 31, 2024 | USD 10.53 | 0.30% |
|
Japan |
|
34 |
USD 533.60 M
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
35 |
USD 517.61 M
|
Sept. 30, 2024 | USD 88.18 | 1.15% |
|
United States |
|
36 |
USD 516.07 M
|
March 31, 2024 | USD 9.21 | 3.00% |
|
Japan |
|
37 |
USD 500.56 M
|
Dec. 31, 2023 | USD 0.54 | 1.42% |
|
China |
|
38 |
USD 454.20 M
|
Dec. 31, 2023 | USD 0.30 | -1.09% |
|
Brazil |
|
39 |
USD 448.79 M
|
Sept. 30, 2024 | USD 46.27 | -3.11% |
|
Germany |
|
40 |
USD 444.07 M
|
Dec. 31, 2023 | USD 4.81 | 3.11% |
|
China |
|
41 |
USD 428.80 M
|
Sept. 30, 2024 | USD 267.04 | -0.35% |
|
United States |
|
42 |
USD 411.16 M
|
Dec. 31, 2023 | USD 38.13 | 0.20% |
|
Italy |
|
43 |
USD 385.99 M
|
June 30, 2024 | USD 185.40 | -0.68% |
|
Australia |
|
44 |
USD 351.36 M
|
Dec. 31, 2023 | USD 50.29 | 3.14% |
|
Germany |
|
45 |
USD 349.92 M
|
Dec. 31, 2023 | USD 1.91 | 1.25% |
|
Brazil |
|
46 |
USD 349.00 M
|
Sept. 30, 2024 | USD 111.11 | 1.26% |
|
United States |
|
47 |
USD 333.42 M
|
Dec. 31, 2023 | USD 0.94 | 3.63% |
|
China |
|
48 |
USD 332.15 M
|
Dec. 31, 2023 | USD 1.49 | 3.42% |
|
China |
|
49 |
USD 322.25 M
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
50 |
USD 314.52 M
|
Dec. 31, 2023 | USD 31.30 | -0.30% |
|
United Kingdom |
The Medical Instruments company with the highest EBITDA is Thermo Fisher Scientific Inc. (NYSE: TMO) at USD 11.31 B.
The Medical Instruments company with the lowest EBITDA is Heart Test Laboratories, Inc. (NasdaqCM: HSCS) at USD -1.99 B.
The top 10 Medical Instruments companies the Global by EBITDA are Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Stryker Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Boston Scientific Corporation, GE HealthCare Technologies Inc., Zimmer Biomet Holdings, Inc. and Intuitive Surgical, Inc..
The bottom 10 Medical Instruments companies by EBITDA are Heart Test Laboratories, Inc., QuidelOrtho Corporation, MicroPort Scientific Corporation, Vitrolife AB (publ), Mesa Laboratories, Inc., SD BioSensor, Inc, 10x Genomics, Inc., Standard BioTools Inc., Outset Medical, Inc. and iRhythm Technologies, Inc..